Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

2018-2022 Europe Tumor Marker Diagnostics Market: France, Germany, Italy, Spain, UK--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, Technology Trends, Opportunities for Suppliers

Be the first to review this product

SummaryThis comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five...
You can choose to pay by purchase order during checkout

Availability: In stock

$19,700.00

* Required Fields

You can choose to pay by purchase order during checkout
VPGMarketResearch

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Summary

This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Additional Information

Additional Information

Publisher name VPGMarketResearch
Format PDF + Excel
Page count 820
Publication date 25 Jan 2018
Table of contents http://www.vpgcorp.com/webfiles/CANCER/TOCLOT%20EuropeanCancerDiagnosticsMarketTowardaNewFutureforTumorMarkersR&D.pdf

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.